{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:17:49Z","timestamp":1793024269554,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1038\/s41433-023-02666-x","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T09:02:51Z","timestamp":1690794171000},"page":"210-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Combined wide-field imaging in grading diabetic retinopathy"],"prefix":"10.1038","volume":"38","author":[{"given":"Matteo","family":"Menean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Tombolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Fantaguzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3238-9682","authenticated-orcid":false,"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-9581","authenticated-orcid":false,"given":"Giuseppe","family":"Querques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"2666_CR1","doi-asserted-by":"crossref","unstructured":"Early photocoagulation for diabetic retinopathy: ETDRS Report Number 9. Ophthalmology. 1991;98:786\u2013806.","DOI":"10.1016\/S0161-6420(13)38012-9"},{"key":"2666_CR2","doi-asserted-by":"crossref","unstructured":"Sacconi R, Casaluci M, Borrelli E, Mulinacci G, Lamanna F, Gelormini F, et al. Multimodal imaging assessment of vascular and neurodegenerative retinal alterations in type 1 diabetic patients without fundoscopic signs of diabetic retinopathy. J Clin Med. 2019;8:1409.","DOI":"10.3390\/jcm8091409"},{"key":"2666_CR3","doi-asserted-by":"crossref","unstructured":"Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677\u201382.","DOI":"10.1016\/S0161-6420(03)00475-5"},{"key":"2666_CR4","doi-asserted-by":"crossref","unstructured":"Solomon SD, Goldberg MF. ETDRS grading of diabetic retinopathy: still the gold standard? Ophthalmic Research. 2019;62:190\u20135.","DOI":"10.1159\/000501372"},{"key":"2666_CR5","doi-asserted-by":"crossref","unstructured":"Classification of diabetic retinopathy from fluorescein angiograms: ETDRS Report Number 11. Ophthalmology. 1991;98:807\u201322.","DOI":"10.1016\/S0161-6420(13)38013-0"},{"key":"2666_CR6","doi-asserted-by":"crossref","unstructured":"Soares M, Neves C, Marques IP, Pires I, Schwartz C, Costa M\u00c2, et al. Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography. Br J Ophthalmol. 2017;101:62\u20138.","DOI":"10.1136\/bjophthalmol-2016-309424"},{"key":"2666_CR7","doi-asserted-by":"crossref","unstructured":"Grading diabetic retinopathy from stereoscopic color fundus photographs \u2014 an extension of the modified airlie house classification: ETDRS Report Number 10. Ophthalmology. 2020;127:786\u2013806.","DOI":"10.1016\/j.ophtha.2020.01.030"},{"key":"2666_CR8","doi-asserted-by":"crossref","unstructured":"Early Treatment Diabetic Retinopathy Study Design and Baseline Patient Characteristics: ETDRS Report Number 7. Ophthalmology. 1991;98:741\u201356.","DOI":"10.1016\/S0161-6420(13)38009-9"},{"key":"2666_CR9","doi-asserted-by":"crossref","unstructured":"Lee CS, Lee AY, Sim DA, Keane PA, Mehta H, Zarranz-Ventura J, et al. Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography. Am J Ophthalmol. 2015;159:101\u201310.e1.","DOI":"10.1016\/j.ajo.2014.09.041"},{"key":"2666_CR10","doi-asserted-by":"crossref","unstructured":"Schaal KB, Munk MR, Wyssmueller I, Berger LE, Zinkernagel MS, Wolf S. Vascular abnormalities in diabetic retinopathy assessed with swept-source optical coherence tomography angiography widefield imaging. Retina. 2019;39:79\u201387.","DOI":"10.1097\/IAE.0000000000001938"},{"key":"2666_CR11","doi-asserted-by":"crossref","unstructured":"McHugh ML. Interrater reliability: The kappa statistic. Biochem Med. 2012;22:276\u201382.","DOI":"10.11613\/BM.2012.031"},{"key":"2666_CR12","doi-asserted-by":"crossref","unstructured":"Arya M, Sorour O, Chaudhri J, Alibhai Y, Waheed NK, Duker JS, et al. Distinguishing intraretinal microvascular abnormalities from retinal neovascularization using optical coherence tomography angiography. Retina. 2020;40:1686\u201395.","DOI":"10.1097\/IAE.0000000000002671"},{"key":"2666_CR13","doi-asserted-by":"crossref","unstructured":"Cui Y, Zhu Y, Wang JC, Lu Y, Zeng R, Katz R, et al. Comparison of widefield swept-source optical coherence tomography angiography with ultra-widefield colour fundus photography and fluorescein angiography for detection of lesions in diabetic retinopathy. Br J Ophthalmol. 2021;105:577\u201381.","DOI":"10.1136\/bjophthalmol-2020-316245"},{"key":"2666_CR14","doi-asserted-by":"crossref","unstructured":"Wang M, Garg I, Miller JB. Wide field swept source optical coherence tomography angiography for the evaluation of proliferative diabetic retinopathy and associated lesions: a review. Semin Ophthalmol. 2021;36:162\u20137.","DOI":"10.1080\/08820538.2021.1887901"},{"key":"2666_CR15","doi-asserted-by":"crossref","unstructured":"Li M, Mao M, Wei D, Liu M, Liu X, Leng H, et al. Different scan areas affect the detection rates of diabetic retinopathy lesions by high-speed ultra-widefield swept-source optical coherence tomography angiography. Front Endocrinol. 2023;14:1111360.","DOI":"10.3389\/fendo.2023.1111360"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02666-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T08:10:42Z","timestamp":1704269442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02666-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2666"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02666-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2210134\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"27 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MM, BT, FF have nothing to disclose. RS has the following disclosures: Allergan Inc, Bayer Shering-Pharma, Medivis, Novartis, Zeiss. FB has the following disclosures: Allergan Inc, Bayer Shering-Pharma, Boehringer-Ingelheim, Fidia Sooft, Hofmann La Roche, Novartis, NTC Pharma, Oxurion NV, Sifi. GQ has the following disclosures: Alimera Sciences, Allergan Inc, Amgen, Bayer Shering-Pharma, Heidelberg, KBH, LEH Pharma, Lumithera, Novartis, Sandoz, Sifi, Sooft-Fidea, Zeiss. The authors have no competing interest in publishing the present work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}